Minimally invasive transforaminal lumbar interbody fusion


Objective:

Instrumented fusion of lumbar motion segments using a minimally invasive technique.


Indications:

Degenerative disc disease, segmental degeneration, degenerative spondylolisthesis, isthmic spondylolisthesis, pseudarthrosis, other spinal lumbar instabilities, disc prolapse, revision for failed back surgery syndrome, unilateral neuroforaminal stenosis, facet joint arthrosis.


Contraindications:

High-grade spondylolisthesis (Meyerding grades III/IV, spondyloptosis), bilateral nerve root compression, vertebral fractures, tumors, high-grade spinal instabilities, primary spinal deformities, multilevel pathologies.


Surgical technique:

Ipsilateral minimally invasive approach using a self-retaining tubular retractor system, partial or complete facetectomy, insertion of pedicle screws, transforaminal lumbar interbody fusion (TLIF) cage insertion preserving nerve roots, fusion, contralateral insertion of pedicle screws using a minimally invasive or percutaneous technique.


Postoperative management:

Mobilization with physiotherapy, followed by standing plain x‑ray examinations, clinical and radiological follow-up at 6-12 weeks and 1 year postoperatively.


Results:

Fusion rates >90%, comparable to open TLIF. Complication rates lower than open TLIF. Shorter radiation exposure during surgery, lower blood loss. Less surgical trauma leads to shorter hospitalization time and earlier return-to-work. Oswestry Disability index (ODI) scores and visual analog scale (VAS) scores significantly decreased.


Keywords:

Complication rate; Degenerative disc disease; Foraminal stenosis; Fusion rate; Spondylolisthesis.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on vk
VK
Share on pinterest
Pinterest
Close Menu